Beneficial Effects of Probiotic Bifidobacterium and Galacto-Oligosaccharide in Patients with Ulcerative Colitis: A Randomized Controlled Study

Probiotics in man and animals

AFRC, R. F. (1989) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1989.tb05105.x · Cited by 4,831

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285

Synbiotic therapy ( Bifidobacterium longum /Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

Furrie, E., Macfarlane, S., Kennedy, A., Cummings, J. H., Walsh, S. V., O’Neil, D. A., & Macfarlane, G. T. (2005) · Gut · doi:10.1136/gut.2004.044834 · Cited by 766

VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

Bibiloni, R., Fedorak, R. N., Tannock, G. W., Madsen, K. L., Gionchetti, P., Campieri, M., Simone, C. D., & Sartor, R. B. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41794.x · Cited by 743

Randomized placebo‐controlled trial assessing the effect of bifidobacteria‐fermented milk on active ulcerative colitis

Kato, K., Mizuno, S., Umesaki, Y., Ishii, Y., Sugitani, M., Imaoka, A., Otsuka, M., Hasunuma, O., Kurihara, R., Iwasaki, A., et al. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02268.x · Cited by 397

G Protein-Coupled Receptor 43 Is Essential for Neutrophil Recruitment during Intestinal Inflammation

Sina, C., Gavrilova, O., Förster, M., Till, A., Derer, S., Hildebrand, F., Rabe, B., Chalaris, A., Scheller, J., Rehmann, A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900063 · Cited by 385

A pilot trial of Saccharomyces boulardii in ulcerative colitis

Guslandi, M., Giollo, P., & Testoni, P. A. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200306000-00017 · Cited by 383

Randomized Controlled Trial of the Effect of Bifidobacteria-Fermented Milk on Ulcerative Colitis

Ishikawa, H., Akedo, I., Umesaki, Y., Tanaka, R., Imaoka, A., & Otani, T. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719276 · Cited by 369

Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial

Kitajima, H., Sumida, Y., Tanaka, R., Yuki, N., Takayama, H., & Fujimura, M. (1997) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.76.2.f101 · Cited by 315

Bifidobacteria and Their Role as Members of the Human Gut Microbiota

O’Callaghan, A. A., & van Sinderen, D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00925 · Cited by 1,160

Actinobacteria: A relevant minority for the maintenance of gut homeostasis

Binda, C., Lopetuso, L. R., Rizzatti, G., Gibiino, G., Cennamo, V., & Gasbarrini, A. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.02.012 · Cited by 828

Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? IBD treatment targeting the gut microbiome

Khan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T., & Zhang, C. (2019) · Pathogens · doi:10.3390/pathogens8030126 · Cited by 771

Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis

Tojo, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15163 · Cited by 533

Bifidobacteria and Their Health-Promoting Effects

Hidalgo-Cantabrana, C., Delgado, S., Ruiz, L., Ruas-Madiedo, P., Sánchez, B., & Margolles, A. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0010-2016 · Cited by 490

The Role of Probiotic Lactic Acid Bacteria and Bifidobacteria in the Prevention and Treatment of Inflammatory Bowel Disease and Other Related Diseases: A Systematic Review of Randomized Human Clinical Trials

Sáez‐Lara, M. J., Gómez‐Llorente, C., Plaza‐Díaz, J., & Gil, Á. (2015) · BioMed Research International · doi:10.1155/2015/505878 · Cited by 419

Probiotics, prebiotics and amelioration of diseases

Tsai, Y.-L., Lin, T.-L., Chang, C.-J., Wu, T.-R., Lai, W.-F., Lu, C.-C., & Lai, H.-C. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-018-0493-6 · Cited by 388

ESPEN guideline on Clinical Nutrition in inflammatory bowel disease

Bischoff, S. C., Bager, P., Escher, J. C., Forbes, A., Hébuterne, X., Hvas, C. L., Joly, F., Kłęk, S., Krznarić, Ž., Ockenga, J., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2022.12.004 · Cited by 399

Probiotics are a good choice in remission of inflammatory bowel diseases: a meta analysis and systematic review

Ganji‐Arjenaki, M., & Rafieian‐Kopaei, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25911 · Cited by 314

ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease

Bischoff, S. C., Escher, J., Hébuterne, X., Kłęk, S., Krznaric, Z., Schneider, S., Shamir, R., Stardelova, K., Wierdsma, N., Wiskin, A. E., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.11.002 · Cited by 351

The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review

Jakubczyk, D., Leszczyńska, K., & Górska, S. (2020) · Nutrients · doi:10.3390/nu12071973 · Cited by 323

Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease

Dupont, A. W., Richards, Jelinek, K. A., Krill, J. T., Rahimi, E. F., & Ghouri, Y. A. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s27530 · Cited by 303

New Approaches for Bacteriotherapy: Prebiotics, New-Generation Probiotics, and Synbiotics

Patel, R., & DuPont, H. L. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ177 · Cited by 282

Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD

Martyniak, A., Medyńska-Przęczek, A., Wędrychowicz, A., Skoczeń, S., & Tomasik, P. (2021) · Biomolecules · doi:10.3390/biom11121903 · Cited by 264

The intestinal microbiota and its role in human health and disease

Kataoka, K. (2016) · The Journal of Medical Investigation · doi:10.2152/jmi.63.27 · Cited by 223

Beyond Heat Stress: Intestinal Integrity Disruption and Mechanism-Based Intervention Strategies

Lian, P., Braber, S., Garssen, J., Wichers, H. J., Folkerts, G., Fink‐Gremmels, J., & Varasteh, S. (2020) · Nutrients · doi:10.3390/nu12030734 · Cited by 207

Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: A systematic review and meta-analysis

Zhang, X.-F., Guan, X.-X., Tang, Y.-J., Sun, J.-F., Wang, X.-K., Wang, W.-D., & Fan, J.-M. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02503-5 · Cited by 193

Probiotics for maintenance of remission in ulcerative colitis

Iheozor‐Ejiofor, Z., Kaur, L., Gordon, M. A., Baines, P. A., Sinopoulou, V., & Akobeng, A. K. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007443.pub3 · Cited by 193

Nutrition in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition

Miele, E., Shamir, R., Aloi, M., Assa, A., Braegger, C., Bronsky, J., de Ridder, L., Escher, J. C., Hojsak, I., Kolaček, S., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001896 · Cited by 191

Roles of the Polyphenol–Gut Microbiota Interaction in Alleviating Colitis and Preventing Colitis-Associated Colorectal Cancer

Zhao, Y., & Jiang, Q. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa104 · Cited by 191

Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases

Oka, A., & Sartor, R. B. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06090-z · Cited by 188

The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy

Cammarota, G., Ianiro, G., Cianci, R., Bibbò, S., Gasbarrini, A., & Currò, D. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.006 · Cited by 184

Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease

Orel, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i33.11505 · Cited by 177

Malnutrition and Gut Microbiota in Children

Iddrisu, I., Monteagudo-Mera, A., Poveda, C. G., Pyle, S., Shahzad, M. A., Andrews, S. C., & Walton, G. (2021) · Nutrients · doi:10.3390/nu13082727 · Cited by 186

Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation

Ponziani, F. R., Zocco, M. A., D’Aversa, F., Pompili, M., & Gasbarrini, A. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i25.4491 · Cited by 177

Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome

Celiberto, L. S., Graef, F. A., Healey, G. R., Bosman, E. S., Jacobson, K., Sly, L. M., & Vallance, B. A. (2018) · Immunology · doi:10.1111/imm.12939 · Cited by 167

Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders

Currò, D., Ianiro, G., Pecere, S., Bibbò, S., & Cammarota, G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13632 · Cited by 160

Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities

Pandey, H., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Cancers · doi:10.3390/cancers15030866 · Cited by 171

Fiber in the Treatment and Maintenance of Inflammatory Bowel Disease

Wedlake, L. J., Slack, N., Andreyev, J. N., & Whelan, K. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437984.92565.31 · Cited by 160

Galacto-oligosaccharides Protect the Intestinal Barrier by Maintaining the Tight Junction Network and Modulating the Inflammatory Responses after a Challenge with the Mycotoxin Deoxynivalenol in Human Caco-2 Cell Monolayers and B6C3F1 Mice

Akbari, P., Braber, S., Alizadeh, A., Verheijden, K. A. T., Schoterman, M. H. C., Kraneveld, A. D., Garssen, J., & Fink‐Gremmels, J. (2015) · Journal of Nutrition · doi:10.3945/jn.114.209486 · Cited by 147

Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis

Yoshimatsu, Y., Yamada, A., Furukawa, R., Sono, K., Osamura, A., Nakamura, K., Aoki, H., Tsuda, Y., Hosoe, N., Takada, N., et al. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i19.5985 · Cited by 138

Exploring the role of the microbiota member Bifidobacterium in modulating immune-linked diseases

O’Neill, I. J., Schofield, Z., & Hall, L. J. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20170058 · Cited by 131

Therapeutic Microbiology: The Role of Bifidobacterium breve as Food Supplement for the Prevention/Treatment of Paediatric Diseases

Cionci, N. B., Baffoni, L., Gaggìa, F., & Gioia, D. D. (2018) · Nutrients · doi:10.3390/nu10111723 · Cited by 138

Efficacy of Bifidobacterium breve fermented milk in maintaining remission of ulcerative colitis

Matsuoka, K., Uemura, Y., Kanai, T., Kunisaki, R., Suzuki, Y., Yokoyama, K., Yoshimura, N., & Hibi, T. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-4946-2 · Cited by 128

Probiotics and prebiotics in ulcerative colitis

Derikx, L. A. A. P., Dieleman, L. A., & Hoentjen, F. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.02.005 · Cited by 125

Probiotics for inflammatory bowel diseases: a promising adjuvant treatment

Coqueiro, A. Y., Raizel, R., Bonvini, A., Tirapegui, J., & Rogero, M. M. (2018) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2018.1477123 · Cited by 114

The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis

Astó, E., Méndez, I., Audivert, S., Farrán-Codina, A., & Espadaler, J. (2019) · Nutrients · doi:10.3390/nu11020293 · Cited by 117

The emerging role of the gut microbiota and its application in inflammatory bowel disease

Xiu, W., Peng, J., Cai, P., Xia, Y., Yi, C., Shang, A., Akanyibah, F. A., & Mao, F. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117302 · Cited by 117

Biological activity of galacto-oligosaccharides: A review

Mei, Z., Yuan, J., & Li, D. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.993052 · Cited by 100

The administration of probiotics and synbiotics in immune compromised adults: is it safe?

van den Nieuwboer, M., Brummer, R. J., Guarner, F., Morelli, L., Cabana, M. D., & Claassen, E. (2014) · Beneficial Microbes · doi:10.3920/bm2014.0079 · Cited by 99

Perioperative dietary therapy in inflammatory bowel disease.

Adamina, M., Gerasimidis, K., Sigall-Boneh, R., Zmora, O., van Overstraeten, A. D. B., Campmans-Kuijpers, M., Ellul, P., Katsanos, K., Kotze, P., Noor, N., et al. (2019) · Journal of Crohn's & Colitis · doi:10.1093/ecco-jcc/jjz160 · Cited by 86

The Effect of Probiotics and Gut Microbiota on Th17 Cells

Tanabe, S. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.839665 · Cited by 102

Potential role of nutraceutical compounds in inflammatory bowel disease

Larussa, T., Imeneo, M., & Luzza, F. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i14.2483 · Cited by 88

Synbiotics for Improved Human Health: Recent Developments, Challenges, and Opportunities

Krumbeck, J. A., Walter, J., & Hutkins, R. W. (2018) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030117-012757 · Cited by 84

Side Effects Associated with Probiotic Use in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Dore, M. P., Bibbò, S., Fresi, G., Bassotti, G., & Pes, G. M. (2019) · Nutrients · doi:10.3390/nu11122913 · Cited by 83

Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease

Pandey, H., Jain, D., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Intestinal Research · doi:10.5217/ir.2023.00080 · Cited by 95

Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy

Serban, D. E. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615606898 · Cited by 79

Probiotics in the Management of Ulcerative Colitis

Chibbar, R., & Dieleman, L. A. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000368 · Cited by 74

Pathobiology and Potential Therapeutic Value of Intestinal Short-Chain Fatty Acids in Gut Inflammation and Obesity

Soldavini, J., & Kaunitz, J. D. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2744-4 · Cited by 73

Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients

Matijašić, M., Meštrović, T., Perić, M., Paljetak, H. Č., Panek, M., Bender, D. V., Kelečić, D. L., Krznarić, Ž., & Verbanac, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040578 · Cited by 71

Commensal Obligate Anaerobic Bacteria and Health: Production, Storage, and Delivery Strategies

Andrade, J. C., Almeida, D., Domingos, M., Seabra, C. L., Machado, D., Freitas, A. C., & Gomes, A. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00550 · Cited by 80

Probiotics, prebiotics, and synbiotics to prevent or combat air pollution consequences: The gut-lung axis

Keulers, L., Dehghani, A., Knippels, L. M. J., Garssen, J., Papadopoulos, N. G., Folkerts, G., Braber, S., & van Bergenhenegouwen, J. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.119066 · Cited by 72

British Dietetic Association consensus guidelines on the nutritional assessment and dietary management of patients with inflammatory bowel disease

Lomer, M. C. E., Wilson, B., & Wall, C. L. (2022) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.13054 · Cited by 70

Effects of synbiotic therapy in mild-to-moderately active ulcerative colitis: A randomized placebo-controlled study

ALTUN, H. K., Yıldız, E. A., & Akın, M. (2019) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2019.18356 · Cited by 70

Gut microbiota and colorectal cancer

Yamamoto, M., & Matsumoto, S. (2016) · Genes and Environment · doi:10.1186/s41021-016-0038-8 · Cited by 72

Microbial-Derived Tryptophan Catabolites, Kidney Disease and Gut Inflammation

Madella, A. M., van Bergenhenegouwen, J., Garssen, J., Masereeuw, R., & Overbeek, S. A. (2022) · Toxins · doi:10.3390/toxins14090645 · Cited by 70

Targeted Approaches for In Situ Gut Microbiome Manipulation

Lee, H. L., Shen, H., Hwang, I. Y., Ling, H., Yew, W. S., Lee, Y. S., & Chang, M. W. (2018) · Genes · doi:10.3390/genes9070351 · Cited by 68

Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis

Jadhav, A., Jagtap, S., Vyavahare, S., Sharbidre, A. A., & Kunchiraman, B. N. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1268041 · Cited by 72

Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease

Pavel, F. M., Vesa, C. M., Gheorghe, G., Diaconu, C. C., Stoicescu, M., Munteanu, M. A., Babeş, E. E., Ţiţ, D. M., Toma, M. M., & BUNGAU, S. G. (2021) · Diagnostics · doi:10.3390/diagnostics11061090 · Cited by 67

Clinical Evidence for the Microbiome in Inflammatory Diseases

Slingerland, A. E., Schwabkey, Z. I., Wiesnoski, D. H., & Jenq, R. R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00400 · Cited by 65

The effects of probiotic/synbiotic supplementation compared to placebo on biomarkers of oxidative stress in adults: a systematic review and meta-analysis of randomized controlled trials

Pourrajab, B., Fatahi, S., Sohouli, M. H., Găman, M.-A., & Shidfar, F. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1821166 · Cited by 82

Adaptation of bifidobacteria to the gastrointestinal tract and functional consequences

Sánchez, B., Ruíz, L., Gueimonde, M., Ruas‐Madiedo, P., & Margollés, A. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.11.004 · Cited by 66

Exploring the Benefits of Probiotics in Gut Inflammation and Diarrhea—From an Antioxidant Perspective

Li, Q., Zheng, T., Ding, H., Chen, J., Li, B., Zhang, Q., Yang, S., Zhang, S., & Guan, W. (2023) · Antioxidants · doi:10.3390/antiox12071342 · Cited by 69

Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022

Huang, C., Hao, W., Wang, X., Zhou, R., & Lin, Q. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1211271 · Cited by 62

Recent updates on correlation between reactive oxygen species and synbiotics for effective management of ulcerative colitis

Ashique, S., Mishra, N., Garg, A., Sibuh, B. Z., Taneja, P., Rai, G., Djearamane, S., Wong, L. S., Al‐Dayan, N., Roychoudhury, S., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1126579 · Cited by 59

Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier

Chen, S.-J., Liu, X., Liu, J.-P., Xi-yan, Y., & Lu, F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i28.9468 · Cited by 58

Efficacy of Probiotics-Based Interventions as Therapy for Inflammatory Bowel Disease: A Recent Update

Selvamani, S., Mehta, V. K., Enshasy, H. A. E., Thevarajoo, S., Adawi, H. E., Zeini, I. M., Pham, K., Varzakas, T. H., & Abomoelak, B. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2022.02.044 · Cited by 60

Prebiotic Galactooligosaccharide Supplementation in Adults with Ulcerative Colitis: Exploring the Impact on Peripheral Blood Gene Expression, Gut Microbiota, and Clinical Symptoms

Wilson, B., Eyice, Ö., Koumoutsos, I., Lomer, M. C. E., Irving, P. M., Lindsay, J. O., & Whelan, K. (2021) · Nutrients · doi:10.3390/nu13103598 · Cited by 53

Enteric microbiota leads to new therapeutic strategies for ulcerative colitis

Chen, W.-X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15657 · Cited by 52

An introduction of the role of probiotics in human infections and autoimmune diseases

Sales‐Campos, H., Soares, S. D. C., & Oliveira, C. J. F. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2019.1621261 · Cited by 52

Editor’s Highlight: Microbial-Derived 1,4-Dihydroxy-2-naphthoic Acid and Related Compounds as Aryl Hydrocarbon Receptor Agonists/Antagonists: Structure–Activity Relationships and Receptor Modeling

Cheng, Y., Jin, U.-H., Davidson, L. A., Chapkin, R. S., Jayaraman, A., Tamamis, P., Orr, A., Allred, C., Denison, M. S., Soshilov, A., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfw230 · Cited by 48

The Role of Probiotics in Inducing and Maintaining Remission in Crohn’s Disease and Ulcerative Colitis: A Systematic Review of the Literature

Vakadaris, G., Stefanis, C., Giorgi, E., Brouvalis, M., Voidarou, C. C., Kourkoutas, Y., Tsigalou, C., & Bezirtzoglou, E. (2023) · Biomedicines · doi:10.3390/biomedicines11020494 · Cited by 54

Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy

Hetta, ‏. F., Ramadan, Y. N., Alharbi, A. A., Alsharif, S. M., Alkindy, T. T., Alkhamali, A., Albalawi, A. S., & El‐Amin, H. (2024) · Immuno · doi:10.3390/immuno4040026 · Cited by 54

Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity

Meng, X. L., Zhou, H., Shen, H., Lufumpa, E., Li, X., Guo, B., & Li, B. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.03.006 · Cited by 46

Prebiotics and synbiotics in ulcerative colitis

Laurell, A., & Sjöberg, K. (2016) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2016.1263680 · Cited by 44

The Communication Between Intestinal Microbiota and Ulcerative Colitis: An Exploration of Pathogenesis, Animal Models, and Potential Therapeutic Strategies

Hu, Y., Ye, Z., Wu, M., She, Y., Li, L., Xu, Y.-J., Qin, K., Hu, Z., Yang, M., Lu, F., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.766126 · Cited by 44

Prebiotic Enriched Exclusive Enteral Nutrition Suppresses Colitis via Gut Microbiome Modulation and Expansion of Anti-inflammatory T Cells in a Mouse Model of Colitis

Lunken, G., Tsai, K., Schick, A., Lisko, D. J., Cook, L. E., Vallance, B. A., & Jacobson, K. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.06.011 · Cited by 42

Probiotics for inflammatory bowel disease: Is there sufficient evidence?

Ma, Y., Yang, D., Huang, J., Liu, K., Liu, H., Wu, H., & Bao, C. (2024) · Open Life Sciences · doi:10.1515/biol-2022-0821 · Cited by 42

A comprehensive review on clinical outcome of probiotic and synbiotic therapy for inflammatory bowel diseases

Sivamaruthi, B. S. (2018) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/2221-1691.228000 · Cited by 42

Integrative analysis of single-cell RNA-seq and gut microbiome metabarcoding data elucidates macrophage dysfunction in mice with DSS-induced ulcerative colitis

Hong, D., Kim, H. K., Yang, W., Yoon, C., Kim, M., Yang, C., & Yoon, S. (2024) · Communications Biology · doi:10.1038/s42003-024-06409-w · Cited by 40

Physiological Characteristics of Lactobacillus casei Strains and Their Alleviation Effects against Inflammatory Bowel Disease

Liu, Y., Li, Y., Yu, X., Yu, L., Tian, F., Zhao, J., Zhang, H., Zhai, Q., & Chen, W. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2003.03041 · Cited by 39

Prebiotics and Inflammatory Bowel Disease

Rasmussen, H. E., & Hamaker, B. R. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.08.004 · Cited by 38

Therapeutic applications of probiotics in ulcerative colitis: An updated review

Dhillon, P., & Singh, K. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100194 · Cited by 37

Prebiotic–Probiotic Relationship: The Genetic Fundamentals of Polysaccharides Conversion by Bifidobacterium and Lactobacillus Genera

Petrova, P. M., & Petrov, K. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811413-1.00007-3 · Cited by 38

Bacillus licheniformis Zhengchangsheng® attenuates DSS-induced colitis and modulates the gut microbiota in mice

Li, Y., Liu, M., Zhou, J., Hou, B., Su, X.-H., Liu, Z., Yuan, J., & Li, M. (2019) · Beneficial Microbes · doi:10.3920/bm2018.0122 · Cited by 32

Protective Effect of Probiotics Isolated from Traditional Fermented Tea Leaves (Miang) from Northern Thailand and Role of Synbiotics in Ameliorating Experimental Ulcerative Colitis in Mice

Kangwan, N., Kongkarnka, S., Boonkerd, N., Unban, K., Shetty, K., & Khanongnuch, C. (2022) · Nutrients · doi:10.3390/nu14010227 · Cited by 33

Bifidobacteria and Their Health-Promoting Effects

Hidalgo-Cantabrana, C., Delgado, S., Ruíz, L., Ruas‐Madiedo, P., Sánchez, B., & Margollés, A. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch3 · Cited by 32

Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn-, or postbiotics?

Lê, A., Mantel, M., Marchix, J., Bodinier, M., Jan, G., & Rolli‐Derkinderen, M. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00002.2022 · Cited by 35

Mangiferin attenuates DSS colitis in mice: Molecular docking and in vivo approach

Somani, S. J., Zambad, S. P., & Modi, K. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.04.033 · Cited by 30

Synbiotics improve clinical indicators of ulcerative colitis: systematic review with meta-analysis

Rufino, M. N., da Costa, A. L., Jorge, E. N., Paiano, V. F., Camparoto, M. L., Keller, R., & Bremer‐Neto, H. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab017 · Cited by 30

Medical Application of Substances Derived from Non-Pathogenic Fungi Aspergillus oryzae and A. luchuensis-Containing Koji

Kitagaki, H. (2021) · Journal of Fungi · doi:10.3390/jof7040243 · Cited by 29

Probiotic actions on diseases: implications for therapeutic treatments

Chiu, Y., Lin, S.-L., Tsai, J., & Lin, M. (2014) · Food & Function · doi:10.1039/c3fo60600g · Cited by 28

Refined fiber inulin promotes inflammation‐associated colon tumorigenesis by modulating microbial succinate production

Tian, S., Paudel, D., Hao, F., Neupane, R., Castro, R., Patterson, A. D., Tiwari, A. K., Prabhu, K. S., & Singh, V. (2023) · Cancer Reports · doi:10.1002/cnr2.1863 · Cited by 29

Bifidobacteria in Fermented Dairy Foods: A Health Beneficial Outlook

Jena, R., & Choudhury, P. K. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10189-w · Cited by 38

Bugs and Guts

Barnes, D. M., & Yeh, A. M. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615610081 · Cited by 28

First and second generation probiotic therapeutics for Inflammatory Bowel Disease

Sireswar, S., Ghosh, I., & Dey, G. (2019) · PharmaNutrition · doi:10.1016/j.phanu.2019.100159 · Cited by 26

Synergy between oligosaccharides and probiotics: From metabolic properties to beneficial effects

Han, D., Żulewska, J., Xiong, K., & Yang, Z. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2139218 · Cited by 27

Diverse galactooligosaccharides consumption by bifidobacteria: implications of β-galactosidase—LacS operon

Akiyama, T., Kimura, K., & Hatano, H. (2014) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2014.987204 · Cited by 29

Probiotics and Their Metabolites Ameliorate Inflammatory Bowel Disease: A Critical Review

Liang, Y., Liu, M., Pu, J., Zhu, Z., Gao, Z., Zhou, Q., Gu, Q., & Li, P. (2020) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000046 · Cited by 26

P0896 A double-blind, randomized, placebo-controlled, single-center, pilot study evaluating the efficacy of a synbiotic formulation in modulating gut microbiota biodiversity in patients with mild-to-moderate UC in clinical and endoscopic remission

Murgiano, M., Bartocci, B., Gaudio, A. D., Rozera, T., Puca, P., Parisio, L., Mignini, I., Coppola, G., Biasio, F. D., Lavigna, D., et al. (2025) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae190.1070

A double-blind, randomized, placebo-controlled, single-center, pilot study evaluating the role of a L. rhamnosus GG-based symbiotic formulation in patients with mild-to-moderate uc in clinical and endoscopic remission

Lopetuso, L., Murgiano, M., Bartocci, B., Rozera, T., GAUDIO, A. D., Puca, P., Parisio, L., Coppola, G., Laterza, L., Pugliese, D., et al. (2025) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.26355/mhd_20259_1343

Synbiotic therapy ( Bifidobacterium longum /Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

Furrie, E., Macfarlane, S., Kennedy, A., Cummings, J. H., Walsh, S. V., O’Neil, D. A., & Macfarlane, G. T. (2005) · Gut · doi:10.1136/gut.2004.044834 · Cited by 766

Effects of synbiotic therapy in mild-to-moderately active ulcerative colitis: A randomized placebo-controlled study

ALTUN, H. K., Yıldız, E. A., & Akın, M. (2019) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2019.18356 · Cited by 70

Synbiotic supplementation containing Bifidobacterium infantis and xylooligosaccharides alleviates dextran sulfate sodium-induced ulcerative colitis

Sheng, K., He, S., Sun, M., Zhang, G., Kong, X., Wang, J., & Wang, Y. (2020) · Food & Function · doi:10.1039/d0fo00518e · Cited by 102